Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 2
1989 3
1990 3
1991 3
1992 3
1993 5
1994 2
1995 3
1996 3
1997 11
1998 7
1999 7
2000 7
2001 7
2002 8
2003 6
2004 16
2005 12
2006 9
2007 10
2008 19
2009 17
2010 20
2011 27
2012 25
2013 39
2014 47
2015 45
2016 42
2017 50
2018 61
2019 53
2020 61
2021 55
Text availability
Article attribute
Article type
Publication date

Search Results

622 results
Results by year
Filters applied: . Clear all
Page 1
Haemodynamic definitions and updated clinical classification of pulmonary hypertension.
Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, Williams PG, Souza R. Simonneau G, et al. Eur Respir J. 2019 Jan 24;53(1):1801913. doi: 10.1183/13993003.01913-2018. Print 2019 Jan. Eur Respir J. 2019. PMID: 30545968 Free PMC article. Review.
Since the 1st World Symposium on Pulmonary Hypertension (WSPH) in 1973, pulmonary hypertension (PH) has been arbitrarily defined as mean pulmonary arterial pressure (mPAP) 25 mmHg at rest, measured by right heart catheterisation. ...However, thi …
Since the 1st World Symposium on Pulmonary Hypertension (WSPH) in 1973, pulmonary hypertension (PH) has been arb …
Risk stratification and medical therapy of pulmonary arterial hypertension.
Galiè N, Channick RN, Frantz RP, Grünig E, Jing ZC, Moiseeva O, Preston IR, Pulido T, Safdar Z, Tamura Y, McLaughlin VV. Galiè N, et al. Eur Respir J. 2019 Jan 24;53(1):1801889. doi: 10.1183/13993003.01889-2018. Print 2019 Jan. Eur Respir J. 2019. PMID: 30545971 Free PMC article. Review.
Pulmonary arterial hypertension (PAH) remains a severe clinical condition despite the availability over the past 15 years of multiple drugs interfering with the endothelin, nitric oxide and prostacyclin pathways. ...
Pulmonary arterial hypertension (PAH) remains a severe clinical condition despite the availability over the past 15 years of m
Definitions and diagnosis of pulmonary hypertension.
Hoeper MM, Bogaard HJ, Condliffe R, Frantz R, Khanna D, Kurzyna M, Langleben D, Manes A, Satoh T, Torres F, Wilkins MR, Badesch DB. Hoeper MM, et al. J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D42-50. doi: 10.1016/j.jacc.2013.10.032. J Am Coll Cardiol. 2013. PMID: 24355641 Free article. Review.
Pulmonary hypertension (PH) is defined by a mean pulmonary artery pressure 25 mm Hg at rest, measured during right heart catheterization. There is still insufficient evidence to add an exercise criterion to this definition. The term pulmonary arterial
Pulmonary hypertension (PH) is defined by a mean pulmonary artery pressure 25 mm Hg at rest, measured during right hear
Cardiopulmonary Hemodynamics in Pulmonary Hypertension and Heart Failure: JACC Review Topic of the Week.
Maron BA, Kovacs G, Vaidya A, Bhatt DL, Nishimura RA, Mak S, Guazzi M, Tedford RJ. Maron BA, et al. J Am Coll Cardiol. 2020 Dec 1;76(22):2671-2681. doi: 10.1016/j.jacc.2020.10.007. J Am Coll Cardiol. 2020. PMID: 33243385 Review.
Pulmonary hypertension (PH) is an independent risk factor for adverse clinical outcome, particularly in left heart disease (LHD) patients. Recent advances have clarified the mean pulmonary artery pressure (mPAP) range that is above normal and is associated wi
Pulmonary hypertension (PH) is an independent risk factor for adverse clinical outcome, particularly in left heart disease (LH
Pulmonary Complications of Portal Hypertension.
Cartin-Ceba R, Krowka MJ. Cartin-Ceba R, et al. Clin Liver Dis. 2019 Nov;23(4):683-711. doi: 10.1016/j.cld.2019.06.003. Epub 2019 Aug 9. Clin Liver Dis. 2019. PMID: 31563218 Review.
The most common pulmonary complications of chronic liver disease are hepatic hydrothorax, hepatopulmonary syndrome, and portopulmonary hypertension. ...Hepatopulmonary syndrome is characterized by low pulmonary vascular resistance secondary to intrapulmonary …
The most common pulmonary complications of chronic liver disease are hepatic hydrothorax, hepatopulmonary syndrome, and portopulmonar …
Pulmonary arterial hypertension: epidemiology and registries.
McGoon MD, Benza RL, Escribano-Subias P, Jiang X, Miller DP, Peacock AJ, Pepke-Zaba J, Pulido T, Rich S, Rosenkranz S, Suissa S, Humbert M. McGoon MD, et al. J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D51-9. doi: 10.1016/j.jacc.2013.10.023. J Am Coll Cardiol. 2013. PMID: 24355642 Free article. Review.
Registries of patients with pulmonary arterial hypertension (PAH) have been instrumental in characterizing the presentation and natural history of the disease and provide a basis for prognostication. ...Considerations for future directions of registry studies includ …
Registries of patients with pulmonary arterial hypertension (PAH) have been instrumental in characterizing the presentation an …
Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.
Shah SJ, Kitzman DW, Borlaug BA, van Heerebeek L, Zile MR, Kass DA, Paulus WJ. Shah SJ, et al. Circulation. 2016 Jul 5;134(1):73-90. doi: 10.1161/CIRCULATIONAHA.116.021884. Circulation. 2016. PMID: 27358439 Free PMC article. Review.
In HFpEF, extracardiac comorbidities such as metabolic risk, arterial hypertension, and renal insufficiency drive left ventricular remodeling and dysfunction through systemic inflammation and coronary microvascular endothelial dysfunction. ...Systemic inflammation also aff …
In HFpEF, extracardiac comorbidities such as metabolic risk, arterial hypertension, and renal insufficiency drive left ventricular re …
Treatment Barriers in Portopulmonary Hypertension.
AbuHalimeh B, Krowka MJ, Tonelli AR. AbuHalimeh B, et al. Hepatology. 2019 Jan;69(1):431-443. doi: 10.1002/hep.30197. Epub 2018 Dec 18. Hepatology. 2019. PMID: 30063259 Free PMC article. Review.
Portopulmonary hypertension (PoPH) is a form of pulmonary arterial hypertension (PAH) that can develop as a complication of portal hypertension. ...
Portopulmonary hypertension (PoPH) is a form of pulmonary arterial hypertension (PAH) that can develop as a complicatio …
Transposition of the great arteries.
Warnes CA. Warnes CA. Circulation. 2006 Dec 12;114(24):2699-709. doi: 10.1161/CIRCULATIONAHA.105.592352. Circulation. 2006. PMID: 17159076 Review.
Long-term problems include coronary stenoses, distortion of the pulmonary arteries, dilatation of the neoaortic root, and aortic regurgitation. ...Associated defects, such as abnormalities of the tricuspid valve, ventricular septal defect, and pulmonary stenosis, oc …
Long-term problems include coronary stenoses, distortion of the pulmonary arteries, dilatation of the neoaortic root, and aortic regu …
Chronic Thromboembolic Pulmonary Hypertension-Management Strategies and Outcomes.
Ranka S, Mohananey D, Agarwal N, Verma BR, Villablanca P, Mewhort HE, Ramakrishna H. Ranka S, et al. J Cardiothorac Vasc Anesth. 2020 Sep;34(9):2513-2523. doi: 10.1053/j.jvca.2019.11.019. Epub 2019 Nov 20. J Cardiothorac Vasc Anesth. 2020. PMID: 31883688 Review.
Chronic thromboembolic pulmonary hypertension (CTEPH) is rare but complex pathophysiological disease with hallmark features of chronic thrombotic mechanical obstruction, right ventricular dysfunction, and secondary pulmonary arteriopathy. ...There has been a …
Chronic thromboembolic pulmonary hypertension (CTEPH) is rare but complex pathophysiological disease with hallmark features of …
622 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page